Mounjaro, known generically as Tirzepatide, is not only a GLP-1 receptor agonist but also incorporates the effects of GIP (Glucose-dependent Insulinotropic Polypeptide)
By acting on those three hormone pathways at once, retatrutide is thought to: Reduce appetite and increase fullness, so eating less feels natural rather than forced
Cardiac and Renal Considerations Due to the glucagon component, some participants experienced a transient increase in heart rate during the first few months of treatment
There are reports of persons using GLP-1 inhibitors losing their interest in alcohol, says Anne McTiernan, MD, PhD, an internist and epidemiologist at Fred Hutchinson Cancer Center in Seattle, who studies ways to prevent cancer through lifestyle changes like weight loss
Guo H, Guo Q, Li Z, Wang Z
Meanwhile, dual agonists, which target and activate both the GLP-1 (Glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, and triple agonists (targeting the GLP-1+GIP+Glucagon receptors) are also showing promise